DGI:Pharmakologische Aspekte/Quellen

AWMF S3-Leitlinie Strategien zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus. Version 2.1. Registernummer 092-001. Stand 31.01.2019. Abrufdatum 11.09.2024

AWMF S2k-Leitlinie Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen. Version 1.2. Registernummer 082-006. Stand 01.12.2027. Abrufdatum 11.09.2024

Tabelle aus Antibiotika-Verordnungen in der ambulanten Versorgung in Hessen 2013–2019 (laekh.de), Abb. 2b. Angepasst. Abrufdatum 30.09.2024

Rybak et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020 May 19;77(11):835-864

Lim et al. Area-Under-Curve-Guided Versus Trough-Guided Monitoring of Vancomycin and Its Impact on Nephrotoxicity: A Systematic Review and Meta-Analysis. Ther Drug Monit. 2023 Aug 1;45(4):519-532

Abdelmessih et al. Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta-analysis. Pharmacotherapy. 2022 Sep;42(9):741-753

Abbasi et al. Recommendations of Gentamicin Dose Based on Different Pharmacokinetic/Pharmacodynamic Targets for Intensive Care Adult Patients: A Redefining Approach Clin Pharmacol. 2023 Jul 4:15:67-76. doi: 10.2147/CPAA.S417298

Rybak et al. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity Antimicrob Agents Chemother. 1999 Jul;43(7):1549-55